STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 520.6 INR | +0.04% |
|
-4.49% | -2.65% |
| Apr. 30 | Transcript : Star Health and Allied Insurance Company Limited, Q4 2024 Earnings Call, Apr 30, 2024 | |
| Apr. 30 | Star Health and Allied Insurance's Human Resources Chief to Retire in July | MT |
Summary
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's profit outlook over the next few years is a strong asset.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- With an expected P/E ratio at 35.31 and 27.49 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -2.65% | 3.65B | C- | ||
| +12.07% | 78.88B | B- | ||
| +9.44% | 51.46B | B+ | ||
| +8.93% | 51.07B | B | ||
| +20.90% | 46.59B | B+ | ||
| +16.04% | 43.21B | B+ | ||
| +23.53% | 39.69B | B | ||
| -0.60% | 29.1B | B | ||
| -6.79% | 27.94B | B- | ||
| -15.80% | 26.05B | A- |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- STARHEALTH Stock
- Ratings Star Health and Allied Insurance Company Limited
